These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 8397460

  • 1. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH, Chung JB, Park IS, Kim BS, Yoo NC, Choi JH, Roh JK, Kim HS, Kwon OH, Lee KS.
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [Abstract] [Full Text] [Related]

  • 2. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
    Tong AW, Su D, Mues G, Tillery GW, Goldstein R, Klintmalm G, Stone MJ.
    Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G.
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S, Morjani H, Poullain MG, Manfait M.
    Anticancer Res; 1994 Nov; 14(6A):2389-93. PubMed ID: 7825978
    [Abstract] [Full Text] [Related]

  • 7. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
    Hamilton G, Cosentini EP, Teleky B, Koperna T, Zacheri J, Riegler M, Feil W, Schiessel R, Wenzi E.
    Anticancer Res; 1993 Nov; 13(6A):2059-63. PubMed ID: 7905252
    [Abstract] [Full Text] [Related]

  • 8. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY, Rowlands MG, Jarman M, Kelland LR.
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [Abstract] [Full Text] [Related]

  • 9. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
    Massart C, Gibassier J, Lucas C, Pourquier P, Robert J.
    Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.
    Hu XF, Martin TJ, Bell DR, de Luise M, Zalcberg JR.
    Cancer Res; 1990 May 15; 50(10):2953-7. PubMed ID: 2334897
    [Abstract] [Full Text] [Related]

  • 12. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
    Page RL, Hughes CS, Huyan S, Sagris J, Trogdon M.
    Anticancer Res; 2000 May 15; 20(5B):3533-8. PubMed ID: 11131658
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
    Zhou Y, Ling XL.
    Chin J Cancer; 2010 Feb 15; 29(2):167-71. PubMed ID: 20109345
    [Abstract] [Full Text] [Related]

  • 15. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
    Lavie Y, Cao Ht, Volner A, Lucci A, Han TY, Geffen V, Giuliano AE, Cabot MC.
    J Biol Chem; 1997 Jan 17; 272(3):1682-7. PubMed ID: 8999846
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr 17; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 17. Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
    Cowie FJ, Pritchard-Jones K, Renshaw J, Pinkerton CR.
    Int J Oncol; 1998 May 17; 12(5):1143-9. PubMed ID: 9538141
    [Abstract] [Full Text] [Related]

  • 18. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Hill BT, Hosking LK.
    Cancer Chemother Pharmacol; 1994 May 17; 33(4):317-24. PubMed ID: 8281626
    [Abstract] [Full Text] [Related]

  • 19. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
    Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ, Hsieh CY, Lai MK, Tsai TC.
    Br J Urol; 1996 Jan 17; 77(1):76-85. PubMed ID: 8653321
    [Abstract] [Full Text] [Related]

  • 20. Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells.
    Dönmez Y, Akhmetova L, İşeri ÖD, Kars MD, Gündüz U.
    Cancer Chemother Pharmacol; 2011 Apr 17; 67(4):823-8. PubMed ID: 20563580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.